Oxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease
Abstract
Increasing evidence supports a role of oxidative imbalance, characterized by impaired antioxidant enzymatic activity and increased reactive oxygen species (ROS) production, in mild cognitive impairment (MCI) and Alzheimer's disease (AD) pathogenesis. Hyperhomocysteinemia, another risk factor for AD, also contributes to oxidative damage. Plasma total homocysteine (tHcy) and ROS levels, and total antioxidant capacity (TAC) were determined in 71 AD, 36 MCI and 28 vascular dementia (VaD) patients as well as in 44 age-matched controls. tHcy levels were significantly increased in patients with AD and VaD an a trend towards an increase in multiple domain MCI was observed. TAC was significantly decreased in AD as well as MCI, but not in VaD patients. In AD patients, a negative correlation was found between TAC and disease duration. ROS levels did not differ among groups, but were correlated with age. In conclusion, a pattern characterized by increased tHcy levels and decreased TAC is present in AD as well as MCI patients. While increased tHcy levels were also found in VaD, TAC modifications occur specifically in AD. ROS levels appear to be correlated with age rather than with a specific dementing disorder, thus leading to the hypothesis that oxidative imbalance observed in AD could be due to a decreased TAC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased levels of chemokines and cytokines in plasma and cerebrospinal fluid are a very early event in Alzheimer's disease pathogenesis, even preceding clinical onset, as demonstrated by subjects with mild cognitive impairment who developed AD over time.
“Indeed, chemokines and cytokines increased levels in plasma and CSF are a very early event in AD pathogenesis, even preceding the clinical onset of the disease, as demonstrated by subjects with MCI who developed AD over time, representing a crucial step in the progression of the disease [117,118,119].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [117]
Total antioxidant capacity (TAC) is depleted in plasma samples from AD and MCI patients.
“Total antioxidant capacity (TAC) (including glutathione, ascorbic acid, uric acid, and bilirubin) is measured in plasma samples from AD and MCI patients and has been found depleted [117].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [117]
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · see citing works
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · see citing works
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · see citing works
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,833 · see citing works
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D’Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O’Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,213 · see citing works
Oxidative stress and Alzheimer disease
Christen, Y. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158 · see citing works
Perry, I. J., Morris, R. W., Ebrahim, S. B. J., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 880 · see citing works
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789 · see citing works
Kruman, I. I., Kumaravel, T. S., Lohani, A., Pedersen, W. A., Cutler, R. G., Kruman, Y., Haughey, N. J., Lee, J., Evans, M. K., & Mattson, M. P. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01752.2002 · Cited by 640 · see citing works
Increase of Brain Oxidative Stress in Mild Cognitive Impairment
Praticò, D., Clark, C. M., Liun, F., Lee, V., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 587 · see citing works
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease
Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U., & Mecocci, P. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00031-9 · Cited by 562 · see citing works
Riggs, K., Spiro, A., Tucker, K. L., & Rush, D. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.3.306 · Cited by 504 · see citing works
Electron transport chain defects in Alzheimer's disease brain
Parker, W. D., Parks, J. K., Filley, C. M., & Kleinschmidt-DeMasters, B. K. (1994) · Neurology · doi:10.1212/wnl.44.6.1090 · Cited by 495 · see citing works
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475 · see citing works
Bostom, A. G., Rosenberg, I. H., Silbershatz, H., Jacques, P. F., Selhub, J., D’Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00006 · Cited by 438 · see citing works
Oxidative stress signalling in Alzheimer's disease
Zhu, X., Raina, A. K., Lee, H., Casadesús, G., Smith, M. A., & Perry, G. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.012 · Cited by 390 · see citing works
Abnormalities of mitochondrial enzymes in Alzheimer disease
Gibson, G. E., Sheu, K.-F. R., & Blass, J. P. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050099 · Cited by 345 · see citing works
Bostom, A. G., Silbershatz, H., Rosenberg, I. H., Selhub, J., D’Agostino, R. B., Wolf, P. A., Jacques, P. F., & Wilson, P. W. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1077 · Cited by 318 · see citing works
Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
Praticò, D., & Sung, S. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6209 · Cited by 229 · cited 1× · see citing works
“This evidence clearly indicates that oxidative imbalance and subsequent oxidative stress are early events in AD evolution, and are probably secondary to other mechanisms specific to AD but not present in other neurodegenerative diseases [26].”
BackgroundReduced platelet cytochrome c oxidase activity in Alzheimer's disease
Parker, W. D., Mahr, N., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A., & Cullum, C. M. (1994) · Neurology · doi:10.1212/wnl.44.6.1086 · Cited by 199 · see citing works
Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD
Cottrell, D. A., Blakely, E. L., Johnson, M. A., Ince, P. G., & Turnbull, D. M. (2001) · Neurology · doi:10.1212/wnl.57.2.260 · Cited by 163 · see citing works
Plasma Homocysteine Levels and Risk of Alzheimer Disease
Bissell, M. G. (2006) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(08)70193-2 · Cited by 151 · see citing works
Aksenov, M., Tucker, H., Nair, P., Aksenova, M. V., Butterfield, D., Estus, S., & Markesbery, W. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:2:151 · Cited by 113 · see citing works
Religa, D., Styczyńska, M., Pepłońska, B., Gabryelewicz, T., Pfeffer, A. Z., Chodakowska-Żebrowska, M., Łuczywek, E., Wasiak, B., Stepien, K., Gołębiowski, M., et al. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000070677 · Cited by 104 · see citing works
In Vitro Effect of Homocysteine on Some Parameters of Oxidative Stress in Rat Hippocampus
STRECK, E. L., Vieira, P. S., Wannmacher, C. M. D., Dutra-Filho, C. S., Wajner, M., & Wyse, Â. T. D. S. (2003) · Metabolic Brain Disease · doi:10.1023/a:1023815119931 · Cited by 97 · see citing works
Oxidative stress in kidney transplant patients1
Campise, M., Bamonti, F., Novembrino, C., Ippolito, S., Tarantino, A., Cornelli, U., Lonati, S., Cesana, B. M., & Ponticelli, C. E. (2003) · Transplantation · doi:10.1097/01.tp.0000090344.61975.f0 · Cited by 85 · see citing works
Self-citationPeripheral markers of oxidative stress in probable Alzheimer patients
Repetto, Reides, Evelson, P., Kohan, Lustig, D., & Llesuy (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00506.x · Cited by 76 · see citing works
Bo, R. D., Comi, G. P., Bresolin, N., Castelli, E., Conti, E., Degiuli, A., Ausenda, C. D., & Scarlato, G. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00249-3 · Cited by 75 · see citing works
Self-citationAPOE-??4 in Patients with Alzheimer Disease and Vascular Dementia
Treves, T. A., Bornstein, N. M., Chapman, J., Klimovitzky, S., Verchovsky, R., Asherov, A., Veshchev, I., & Korczyn, A. D. (1996) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199601040-00003 · Cited by 54 · see citing works
Traykov, L. D., Rigaud, A., Baudic, S., Smagghe, A., Boller, F., & Forette, F. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00287-3 · Cited by 40 · see citing works
Guidi, I., Galimberti, D., Venturelli, E., Lovati, C., Bo, R. D., Fenoglio, C., Gatti, A., Dominici, R., Galbiati, S., Virgilio, R., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.003 · Cited by 35 · see citing works
Self-citationAPOE genotype in cerebrovascular disease and vascular dementia
Frank, A., Díez‐Tejedor, E., Bullido, M. J., Valdivieso, F., & Barreiro, P. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00286-1 · Cited by 33 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Review on in vivo and in vitro methods evaluation of antioxidant activity
Alam, M. N., Bristi, N. J., & Rafiquzzaman, M. (2012) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.05.002 · Cited by 1,769 · see citing works
Involvement of oxidative stress in Alzheimer disease
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611 · see citing works
Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564 · see citing works
Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526 · see citing works
Indian medicinal herbs as sources of antioxidants
Ali, S. S., Kasoju, N., Luthra, A., Singh, A., Hallihosur, S., Sahu, A., & Bora, U. (2007) · Food Research International · doi:10.1016/j.foodres.2007.10.001 · Cited by 460 · see citing works
Ch, S., & Dave, R. A. (2009) · African Journal of Microbiology Research · doi:10.5897/ajmr.9000401 · Cited by 406 · see citing works
Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease
Mandal, P. K., Saharan, S., Tripathi, M., & Murari, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.005 · Cited by 339 · see citing works
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis
Schrag, M., Mueller, C., Zabel, M. K., Crofton, A. R., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 335 · see citing works
Role of Oxidative Stress in the Progression of Alzheimer's Disease
Rukhsana Sultana, A., & Butterfield, D. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1222 · Cited by 327 · see citing works
Antioxidant Capacity Determination in Plants and Plant‐Derived Products: A Review
Pisoschi, A. M., Pop, A., Cimpeanu, C. L., & Predoi, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9130976 · Cited by 305 · see citing works
Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease
Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289 · see citing works
Self-citationCognitive enhancement and neuroprotective effects of Bacopa monnieri in alzheimer’s disease model
Uabundit, N., Wattanathorn, J., Mucimapura, S., & Ingkaninan, K. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.056 · Cited by 282 · see citing works
Recent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274 · see citing works
Mild Cognitive Impairment: A Systematic Review
Mariani, E., Monastero, R., & Mecocci, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12104 · Cited by 248 · see citing works
Wang, X., Hu, X., Yang, Y., Takata, T., & Sakurai, T. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.060 · Cited by 217 · see citing works
The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine?
Smith, A. D. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s119 · Cited by 216 · see citing works
Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215 · see citing works
Diet, cognition, and alzheimer’s disease: food for thought
Otaegui-Arrazola, A., Amiano, P., Elbusto, A., Urdaneta, E., & Martínez-Lage, P. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0561-3 · Cited by 214 · see citing works
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease
Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209 · see citing works
Self-citationLipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer Dementias
Casado, Á., López-Fernández, M. E., Casado, M. C., & de la Torre, R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9453-3 · Cited by 207 · see citing works
Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P., & Leuner, K. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8141-5 · Cited by 243 · see citing works
Li, J., Wang, C., Zhang, J. H., Cai, J., Cao, Y., & Sun, X. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.046 · Cited by 204 · see citing works
RetractedHyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies
Tinelli, C., Pino, A. D., Ficulle, E., Marcelli, S., & Feligioni, M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00049 · Cited by 201 · see citing works
Mitochondrial Dysfunction: The First Domino in Brain Aging and Alzheimer's Disease?
Leuner, K., Hauptmann, S., Abdel-Kader, R. M., Scherping, I., Keil, U., Strosznajder, J. B., Eckert, A., & Müller, W. E. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1763 · Cited by 194 · see citing works
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
Rommy von Bernhardi, M., & Eugenín, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 189 · see citing works
Oxidative Damage to RNA in Aging and Neurodegenerative Disorders
Nunomura, A., Moreira, P. I., Castellani, R. J., Lee, H., Zhu, X., Smith, M. A., & Perry, G. L. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9331-x · Cited by 183 · see citing works
Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179 · see citing works
Self-citationMitochondrial DNA Oxidative Damage and Repair in Aging and Alzheimer's Disease
Santos, R. X., Correia, S. C., Zhu, X., Smith, M. A., Moreira, P. I., Castellani, R. J., Nunomura, A., & Perry, G. L. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5039 · Cited by 176 · see citing works
Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 179 · see citing works
The emerging role of glutathione in Alzheimer’s disease
Saharan, S., & Mandal, P. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132483 · Cited by 168 · see citing works
RNA oxidation in Alzheimer disease and related neurodegenerative disorders
Nunomura, A., Hofer, T., Moreira, P. I., Castellani, R. J., Smith, M. A., & Perry, G. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0508-1 · Cited by 148 · see citing works
Chang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 143 · see citing works
Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 137 · see citing works
Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
Guglielmotto, M. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.003.2010 · Cited by 133 · see citing works
López, N., Tormo, C., Blas, I. D., Llinares, I., & Alom, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121528 · Cited by 133 · see citing works
Sompol, P. M., Ittarat, W., Tangpong, J., Chen, Y., Doubinskaia, I. E., Batinic-Haberle, I., Abdul, H. M., Butterfield, D. A., & Clair, D. K. S. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.044 · Cited by 134 · see citing works
Oxidative Damage to RNA in Neurodegenerative Diseases
Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Smith, M. A., & Perry, G. L. (2006) · BioMed Research International · doi:10.1155/jbb/2006/82323 · Cited by 129 · see citing works
Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12107 · Cited by 126 · see citing works
Biomarkers in Alzheimer's disease drug development
Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 121 · see citing works
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain
Hardas, S. S., Sultana, R., Clark, A. M., Beckett, T. L., Szweda, L. I., Murphy, M. P., & Butterfield, D. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.002 · Cited by 120 · see citing works
One-Carbon Metabolism and Alzheimers Disease: Focus on Epigenetics
Coppedè, F. (2010) · Current Genomics · doi:10.2174/138920210791233090 · Cited by 117 · see citing works
Amyloid-β Production: Major Link Between Oxidative Stress and BACE1
Tamagno, E., Guglielmotto, M., Monteleone, D., & Tabaton, M. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9283-6 · Cited by 115 · see citing works
The effect of N-acetylcysteine (NAC) on human cognition – A systematic review
Skvarc, D., Dean, O. M., Byrne, L. K., Gray, L. J., Lane, S. E., Lewis, M., Fernandes, B. S., Berk, M., & Marriott, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.013 · Cited by 108 · see citing works
Dietary diversity and cognitive function among elderly people: A population-based study
Yin, Z. X., Fei, Z., Qiu, C., Brasher, M. S., Kraus, V. B., Zhao, W., Shi, X., & Zeng, Y. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0912-5 · Cited by 110 · see citing works
The effects of long-term honey, sucrose or sugar-free diets on memory and anxiety in rats
Chepulis, L. M., Starkey, N. J., Waas, J. R., & Molan, P. C. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.03.001 · Cited by 108 · see citing works
Environmental and dietary risk factors in Alzheimer’s disease
Dosunmu, R., Wu, J., Basha, R. M., & Zawia, N. H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.887 · Cited by 109 · see citing works
Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model
Chu, Y.-F., Chang, W.-H., Black, R. M., Liu, J.-R., Sompol, P., Chen, Y., Wei, H., Zhao, Q., & Cheng, I. H. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.04.148 · Cited by 106 · see citing works
Cahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 106 · see citing works
Recent Advances in the Treatment of Neurodegenerative Diseases Based on GSH Delivery Systems
Cacciatore, I., Baldassarre, L., Fornasari, E., Mollica, A., & Pinnen, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/240146 · Cited by 106 · see citing works
Cervellati, C., Romani, A., Seripa, D., Cremonini, E., Bosi, C., Magon, S., Passaro, A., Bergamini, C. M., Pilotto, A., & Zuliani, G. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.11.041 · Cited by 101 · see citing works
Tchekalarova, J. D., & Tzoneva, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033022 · Cited by 100 · see citing works
Morais, E. S., Silva, N. H. C. S., Sintra, T. E., Santos, S. A. O., Neves, B. M., Almeida, I. F., Costa, P. C., Correia‐Sá, I., Ventura, S. P. M., Silvestre, A. J. D., et al. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.10.051 · Cited by 90 · see citing works
Blood markers of oxidative stress in A lzheimer's disease
Skoumalová, A., & Hort, J. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01585.x · Cited by 87 · see citing works
Lü, P., Mamiya, T., Lu, L., Mouri, A., Niwa, M., Hiramatsu, M., Zou, L., Nagai, T., Ikejima, T., & Nabeshima, T. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155069 · Cited by 80 · see citing works
Fatty Acids, Antioxidants and Physical Activity in Brain Aging
Freitas, H. R., Ferreira, G. C., Trevenzoli, I. H., Oliveira, K. J., & Reis, R. A. D. M. (2017) · Nutrients · doi:10.3390/nu9111263 · Cited by 82 · see citing works
Kaneria, M., Kanani, B., & Chanda, S. V. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60041-0 · Cited by 79 · see citing works
Association between Helicobacter pylori infection and mild cognitive impairment
Kountouras, J., Tsolaki, M., Boziki, M. K., Gavalas, E., Zavos, C., Stergiopoulos, C., Kapetanakis, N., Chatzopoulos, D., & Venizelos, I. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01827.x · Cited by 80 · see citing works
Nantachai, G., Vasupanrajit, A., Tunvirachaisakul, C., Solmi, M., & Maes, M. H. J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101639 · Cited by 71 · see citing works
Cervellati, C., Cremonini, E., Bosi, C., Magon, S., Zurlo, A., Bergamini, C. M., & Zuliani, G. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040003 · Cited by 70 · see citing works
Use of medical foods and nutritional approaches in the treatment of Alzheimer’s disease
Thaipisuttikul, P., & Galvin, J. E. (2012) · Clinical Practice · doi:10.2217/cpr.12.3 · Cited by 69 · see citing works
Wang, D., Chen, C., Ke, X., Kang, N., Shen, Y., Liu, Y., Zhou, X., Wang, H., Chen, C., & Ren, L. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am5086269 · Cited by 69 · see citing works
Shukla, D., Mandal, P. K., Tripathi, M., Vishwakarma, G., Mishra, R., & Sandal, K. (2019) · Human Brain Mapping · doi:10.1002/hbm.24799 · Cited by 67 · see citing works
Stigger, F. S., Zago Marcolino, M. A., Portela, K. M., & Plentz, R. D. M. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly173 · Cited by 68 · see citing works
Naeini, A. A., Elmadfa, I., Djazayery, A., Barekatain, M., Aghaye-Ghazvini, M. R., Djalali, M., & Feizi, A. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0628-1 · Cited by 68 · see citing works
Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
Wang, Q., Zhao, J., Chang, H., Liu, X., & Zhu, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.665114 · Cited by 67 · see citing works
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
Giovanni, G. D., Štrac, D. Š., Solé, M., Unzeta, M., Tipton, K. F., Mück‐Šeler, D., Bolea, I., Corte, L., Perković, M. N., Pivac, N., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00541 · Cited by 71 · see citing works
Болдырев, А. А., & Johnson, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11209 · Cited by 66 · see citing works
Synthesis, docking studies and antioxidant activity of some chalcone and aurone derivatives
Narsinghani, T., Sharma, M. C., & Bhargav, S. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0413-3 · Cited by 68 · see citing works
Subash, S., Braidy, N., Essa, M. M., Al‐Buraiki, Z., Vaishnav, R., Al‐Adawi, S., Al-Asmi, A. R., & Guillemin, G. J. (2014) · Nutrition · doi:10.1016/j.nut.2014.06.004 · Cited by 65 · see citing works
Zhao, Y., Huang, G., Chen, S., Gou, Y., Dong, Z., & Zhang, X. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081196 · Cited by 65 · see citing works
Cervellati, C., Romani, A., Seripa, D., Cremonini, E., Bosi, C., Magon, S., Bergamini, C. M., Valacchi, G., Pilotto, A., & Zuliani, G. (2014) · BioMed Research International · doi:10.1155/2014/309507 · Cited by 63 · see citing works
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Werder (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6564 · Cited by 57 · see citing works
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
Castellani, R. J., Zhu, X., Lee, H., Smith, M. A., & Perry, G. L. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031386 · Cited by 54 · see citing works
Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?
Kaufman, M. J., Kanayama, G., Hudson, J. I., & Pope, H. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.014 · Cited by 54 · see citing works
Iuliano, L., Monticolo, R., Straface, G., Spoletini, I., Gianni, W., Caltagirone, C., Bossù, P., & Spalletta, G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100780 · Cited by 52 · see citing works
Walker, J., Winhusen, T. M., STORKSON, J. M., Lewis, D. F., Pariza, M. W., Somoza, E. C., & Somoza, V. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2430 · Cited by 51 · see citing works
Doggui, S., Belkacemi, A., Paka, G. D., Perrotte, M., Pi, R., & Ramassamy, C. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300130 · Cited by 51 · see citing works
Nitric Oxide Homeostasis in Neurodegenerative Diseases
Hannibal, L. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921101250 · Cited by 51 · see citing works
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment
Chico, L., Simoncini, C., Gerfo, A. L., Rocchi, A., Petrozzi, L., Carlesi, C., Volpi, L., Tognoni, G., Siciliano, G., & Bonuccelli, U. (2013) · Free Radical Research · doi:10.3109/10715762.2013.804622 · Cited by 51 · see citing works
Oxidative Imbalance in Different Neurodegenerative Diseases with Memory Impairment
Gironi, M., Bianchi, A., Russo, A., Alberoni, M., Ceresa, L., Angelini, A., Cursano, C., Mariani, E., Nemni, R., Kullmann, C., et al. (2010) · Neurodegenerative Diseases · doi:10.1159/000319452 · Cited by 48 · see citing works
Aybek, H., Ercan, F., Aslan, D., & Şahiner, T. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.09.005 · Cited by 48 · see citing works
Liao, J., Hsu, C., Wang, M.-F., Hsu, W.-M., & Chan, Y. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061823 · Cited by 47 · see citing works
BioAge: Toward a multi-determined, mechanistic account of cognitive aging
DeCarlo, C. A., Tuokko, H. A., Williams, D., Dixon, R. A., & MacDonald, S. W. S. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.09.003 · Cited by 46 · see citing works
Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients
Costa, M., Horrillo, R., Ortiz, A. M., Pérez, A., Mestre, A., Ruiz, A., Boada, M., & Grancha, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180243 · Cited by 45 · see citing works
Understanding Redox Homeostasis and Its Role in Cancer
Dawane, J. S. (2012) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2012/4947.2654 · Cited by 44 · see citing works
Frailty Is Related to Subjective Cognitive Decline in Older Women without Dementia
Gifford, K. A., Bell, S. P., Liu, D., Neal, J. E., Turchan, M., Shah, A. S., & Jefferson, A. L. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15972 · Cited by 43 · see citing works
Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease
Castellani, R. J., Nunomura, A., Rolston, R. K., Moreira, P. I., Takeda, A., Perry, G. L., & Smith, M. A. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9050789 · Cited by 43 · see citing works
Al-Hakkani, M. F., Gouda, G. A., Hassan, S. H. A., Saddik, M. S., El‐Mokhtar, M. A., Ibrahim, M. A., Mohamed, M. M. A., & Nagiub, A. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-14922-3 · Cited by 42 · see citing works
Effects of grape seed proanthocyanidin on Alzheimer's disease in vitro and in vivo
Lian, Q., Nie, Y., Zhang, X., Tan, B., Cao, H., Chen, W., Gao, W., Chen, J., Liang, Z., Lai, H., et al. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3530 · Cited by 41 · see citing works
Recent Progress in Autocatalytic Ceria Nanoparticles-Based Translational Research on Brain Diseases
Choi, S. W., & Kim, J. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b02243 · Cited by 39 · see citing works
Izumi, H., Sato, K., Kojima, K., Saito, T., Saido, T. C., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108026 · Cited by 37 · see citing works
NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells
Ferlazzo, N., Condello, S., Currò, M., Parisi, G., Ientile, R., & Caccamo, D. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-62 · Cited by 37 · see citing works
Cognitive impairment and Alzheimer’s disease: Links with oxidative stress and cholesterol metabolism
Maccioni, R. B. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3268 · Cited by 36 · see citing works
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Bobińska, K., & Kowalczyk, E. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0788-z · Cited by 35 · see citing works
Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain
Permpoonputtana, K., Tangweerasing, P., Mukda, S., Boontem, P., Nopparat, C., & Govitrapong, P. (2018) · EXCLI journal · doi:10.17179/excli2017-654 · Cited by 35 · see citing works
Homocysteine and electroencephalographic rhythms in Alzheimer disease: A multicentric study
Babiloni, C., Bosco, P., Ghidoni, R., Percio, C. D., Squitti, R., Binetti, G. G., Benussi, L., Ferri, R., Frisoni, G. B., Lanuzza, B., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.065 · Cited by 35 · see citing works
Wang, G., Ahmeda, A. F., Malek, Z., Mansooridara, S., Zangeneh, A., & Zangeneh, M. M. (2020) · Applied Organometallic Chemistry · doi:10.1002/aoc.5488 · Cited by 34 · see citing works
Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease
Arıkanoğlu, A., Akıl, E., Varol, S., Yavuz, Y., Yüksel, H., Çevik, M. U., Palanci, Y., & Unan, F. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1346-4 · Cited by 34 · see citing works
Makori, W. A., Kibiti, C. M., Njagi, J. M., & Ngugi, M. P. (2019) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x19883258 · Cited by 34 · see citing works
Li, W., Yang, S., Yu, F., Zhao, Y., Sun, Z., An, J., & Ji, E. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.012 · Cited by 32 · see citing works
- Authors
- GUIDI, I., GALIMBERTI, D., LONATI, S., NOVEMBRINO, C., BAMONTI, F., TIRITICCO, M., FENOGLIO, C., VENTURELLI, E., BARON, P., & BRESOLIN, N.
- Affiliations
- University of Milan (IT)
- Corresponding author
- GALIMBERTI, D
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 27
- Issue
- 2
- Pages
- 262-269
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2152628887
- Cited by
- 203
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 10 · 2020: 15 · 2019: 13 · 2018: 11 · 2017: 6 · 2016: 10 · 2015: 4 · 2014: 13 · 2013: 11 · 2012: 16
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative imbalance, mild cognitive impairment, Alzheimer's disease, vascular dementia, hyperhomocysteinemia, total homocysteine, reactive oxygen species, total antioxidant capacity, antioxidant enzymes, oxidative stress, disease duration
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Cocaine, Cognition Disorders, Epinephrine, Female, Homocystine, Humans, Male, Mental Status Schedule, Middle Aged, Retrospective Studies, Sex Factors, Tetracaine, Confidence Intervals, Odds Ratio, Case-Control Studies, Reactive Oxygen Species, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review